Published in Prostate on May 15, 2003
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer (2004) 1.41
DNA methylation of cancer genome. Birth Defects Res C Embryo Today (2009) 1.39
Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol Cancer (2006) 1.38
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Rev Mol Diagn (2009) 1.08
Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int (2010) 1.03
Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med (2006) 1.02
Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. Am J Pathol (2013) 1.00
CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer. J Urol (2008) 1.00
The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring. Clin Epigenetics (2011) 1.00
Promoter hypermethylation in prostate cancer. Cancer Control (2010) 0.99
Aberrant DNA methylation and prostate cancer. Curr Genomics (2011) 0.98
Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis (2011) 0.98
Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res (Phila) (2008) 0.93
Epigenetics in prostate cancer. Prostate Cancer (2011) 0.92
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential. J Cell Mol Med (2014) 0.90
DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol (2012) 0.88
Methylation of the RARB gene increases prostate cancer risk in black Americans. J Urol (2013) 0.86
Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev (2014) 0.85
Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate Cancer. Chin J Cancer Res (2011) 0.84
Prostate cancer epigenetics: a review on gene regulation. Gene Regul Syst Bio (2007) 0.81
Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis (2008) 0.81
Epigenetics in breast and prostate cancer. Methods Mol Biol (2015) 0.79
DNA methylation profiles in African American prostate cancer patients in relation to disease progression. Genomics (2016) 0.79
Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study. Fam Cancer (2016) 0.78
Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells. PLoS One (2012) 0.77
COX-2 (PTGS2) gene methylation in epithelial, subepithelial lymphocyte and stromal tissue compartments in a spectrum of esophageal squamous neoplasia. Cancer Detect Prev (2008) 0.77
Epigenetic Basis of Cancer Health Disparities: Looking Beyond Genetic Differences. Biochim Biophys Acta (2017) 0.76
Racial disparities in prostate cancer: a molecular perspective. Front Biosci (Landmark Ed) (2017) 0.75
Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review. Prostate Cancer Prostatic Dis (2017) 0.75
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. J Transl Med (2016) 0.75
Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins. BMC Cancer (2017) 0.75
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med (2005) 5.05
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51
Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol (2002) 3.23
Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis (2002) 3.22
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet (2007) 3.00
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS (2002) 2.93
Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med (2007) 2.88
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med (2009) 2.67
Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med (2012) 2.60
Incidence of HIV infection in stable sexual partnerships: a retrospective cohort study of 1802 couples in Mwanza Region, Tanzania. J Acquir Immune Defic Syndr (2002) 2.60
Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med (2010) 2.59
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis (2002) 2.39
Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS (2012) 2.15
Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials (2009) 2.14
Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst (2011) 2.13
Evaluation of community level interventions to address social and structural determinants of health: a cluster randomised controlled trial. BMC Public Health (2009) 2.05
A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS One (2010) 1.97
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect (2007) 1.89
Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infect Dis (2005) 1.88
Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob Health (2014) 1.81
Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors. Bull World Health Organ (2007) 1.78
Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania. Trop Med Int Health (2005) 1.64
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients. Cancer Prev Res (Phila) (2012) 1.57
Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. PLoS One (2010) 1.54
HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis (2011) 1.45
Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis (2012) 1.38
Comparison of HIV prevalences in community-based and antenatal clinic surveys in rural Mwanza, Tanzania. AIDS (2002) 1.38
Association between HIV and subpreputial penile wetness in uncircumcised men in South Africa. J Acquir Immune Defic Syndr (2006) 1.36
Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. AIDS Patient Care STDS (2009) 1.32
U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev (2011) 1.31
A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care (2008) 1.30
Methods for the analysis of incidence rates in cluster randomized trials. Int J Epidemiol (2002) 1.29
The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2006) 1.29
The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa. Int J Epidemiol (2003) 1.24
Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. BMC Med (2012) 1.24
Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial. Clin Trials (2008) 1.22
Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 1.21
The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania. BMC Public Health (2007) 1.19
Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS (2009) 1.14
Carotenoid and tocopherol estimates from the NCI diet history questionnaire are valid compared with multiple recalls and serum biomarkers. J Nutr (2006) 1.12
A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett (2004) 1.12
A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila) (2012) 1.11
Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer (2008) 1.11
Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda. J Acquir Immune Defic Syndr (2013) 1.11
Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis (2011) 1.06
Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol Biomarkers Prev (2010) 1.05
Factors impacting questionnaire response in a Dutch retrospective cohort study. Ann Epidemiol (2004) 1.02
Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial. Cancer Epidemiol Biomarkers Prev (2005) 1.01
Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: comparison of opt-out and opt-in strategies. PLoS One (2012) 1.00
The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania. PLoS One (2013) 1.00
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett (2003) 0.98
Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion (2007) 0.98
Low specificity of the Murex fourth-generation HIV enzyme immunoassay in Tanzanian adolescents. Trop Med Int Health (2007) 0.98
Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. Sex Transm Dis (2002) 0.97
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev (2009) 0.97
A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev (2012) 0.97
Cancer incidence in blood transfusion recipients. J Natl Cancer Inst (2007) 0.97
A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States). Cancer Causes Control (2006) 0.97
Measures of between-cluster variability in cluster randomized trials with binary outcomes. Stat Med (2009) 0.96
Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics (2007) 0.96
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women. J Infect Dis (2012) 0.94
Difference in prevalence of common mental disorder as measured using four questionnaire delivery methods among young people in rural Zimbabwe. J Affect Disord (2009) 0.94
Increased condom use at sexual debut in the general population of Slovenia and association with subsequent condom use. AIDS (2005) 0.94
Condom use among female sex workers in Uganda. AIDS Care (2012) 0.92
Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility. Am J Med Genet A (2005) 0.91
Geographical variations in the prevalence of HIV and other sexually transmitted infections in rural Tanzania. Int J STD AIDS (2003) 0.90
The Well London program--a cluster randomized trial of community engagement for improving health behaviors and mental wellbeing: baseline survey results. Trials (2012) 0.90
Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda. Sex Transm Dis (2013) 0.88
Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania. PLoS One (2013) 0.88
Apples and oranges? Interpreting success in HIV prevention trials. Contraception (2010) 0.86
Population estimates of extended family structure and size. Community Genet (2008) 0.86
Control of sexually transmitted infections for HIV prevention. Lancet (2008) 0.86
US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. Sex Health (2010) 0.85
Vaginal practices diary: development of a pictorial data collection tool for sensitive behavioral data. Sex Transm Dis (2012) 0.84
Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. AIDS Behav (2013) 0.83
Personality disorder and self-rated health: a population-based cross-sectional survey. J Pers Disord (2013) 0.82
Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials (2013) 0.82
Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS (2002) 0.81
Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study. Gynecol Oncol (2005) 0.81
Clinical characteristics associated with Mycoplasma genitalium infection among women at high risk of HIV and other STI in Uganda. Sex Transm Dis (2012) 0.81
HIV prevention--where now? Background and introduction. AIDS (2010) 0.80
Prevention of HIV in young people in Africa. BMJ (2008) 0.80
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity. Cancer (2012) 0.80
Community intervention improves knowledge of HIV status of adolescents in Zambia: findings from HPTN 071-PopART for youth study. AIDS (2017) 0.78
Early detection and risk assessment: proceedings and recommendations from the Workshop on Epigenetics in Cancer Prevention. Ann N Y Acad Sci (2003) 0.78
Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung). Cancer J (2013) 0.78
Lymphocyte toxicity and T cell receptor excision circles in workers exposed to benzene. Chem Biol Interact (2005) 0.77
Common leptin receptor polymorphisms do not modify the effect of alcohol ingestion on serum leptin levels in a controlled feeding and alcohol ingestion study. Cancer Epidemiol Biomarkers Prev (2005) 0.77
Ethics, justice and community participation in the Microbicides Development Programme (MDP) Phase III trial in Mwanza, Tanzania. Am J Bioeth (2012) 0.77
Attitudes toward and frequency of partner interactions among women reporting decreased sexual desire. J Sex Med (2009) 0.76
Possible reasons for an increase in the proportion of genital ulcers due to herpes simplex virus from a cohort of female bar workers in Tanzania. Sex Transm Infect (2006) 0.76
Physical activity in deprived communities in London: examining individual and neighbourhood-level factors. PLoS One (2013) 0.76
Insulin receptor variants and obesity-related cancers in the Framingham Heart Study. Cancer Causes Control (2015) 0.76
The front line of genomic translation. J Cancer Epidemiol (2012) 0.75
Reed Elsevier and the arms trade revisited. Lancet (2007) 0.75